In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Femara, Letrozole Drug Master File in Korea (Femara, Letrozole KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Femara, Letrozole. The MFDS reviews the Femara, Letrozole KDMF as part of the drug registration process and uses the information provided in the Femara, Letrozole KDMF to evaluate the safety and efficacy of the drug.
After submitting a Femara, Letrozole KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Femara, Letrozole API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Femara, Letrozole suppliers with KDMF on PharmaCompass.